Form 4: Glaukos COO Joseph Gilliam Reports Equity Awards

Glaukos Corporation's President and COO, Joseph E. Gilliam, reported the acquisition of common stock and stock options through vesting of previously granted equity awards.

Summary

• Joseph E. Gilliam, President & COO of Glaukos Corp (GKOS), reported multiple equity transactions on March 25, 2026, primarily related to the vesting of previously granted awards.
• Acquired 5,829 shares of common stock from a restricted stock unit (RSU) award granted March 14, 2024, which vested upon the Issuer's achievement of pre-determined operational targets.
• Acquired an additional 17,792 shares of common stock from RSUs granted March 25, 2026, which vest over a four-year period, with 25% vesting on each anniversary of the grant date.
• Acquired 16,462 stock options (right to buy) with an exercise price of $55.18, representing a portion of an option granted March 24, 2022, which vested based on operational targets achieved on December 15, 2022.
• Acquired 21,955 stock options (right to buy) with an exercise price of $55.18, related to his promotion to President and COO on March 24, 2022, vesting based on multi-year performance goals, with the fourth-year goal achievement determined on March 25, 2026.
• Acquired 36,751 stock options (right to buy) with an exercise price of $48.46, from an RSU award granted March 22, 2023, which vested upon the Issuer's achievement of pre-determined operational targets.
• Following these transactions, Gilliam beneficially owns 78,369 shares of common stock (including 31,962 unvested RSUs) and 96,161 shares of common stock (including 49,754 unvested RSUs) from the respective RSU grants.
• He also beneficially owns 71,475, 52,668, and 36,751 stock options from the respective grants.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive disclosure, reflecting the achievement of internal operational targets and the vesting of executive compensation, which aligns management's interests with company performance.

Positives

• Achievement of pre-determined operational targets by Glaukos, leading to the vesting of restricted stock units and stock options for the President & COO.
• Vesting of equity awards demonstrates continued alignment of management incentives with company performance and long-term shareholder value creation.
• The awards are part of long-term incentive plans, indicating management's commitment to the company's sustained growth.

Future Outlook

A portion of a stock option award is scheduled to vest and become exercisable in December 2026. Additionally, restricted stock units granted on March 25, 2026, will vest over a four-year period, with 25% vesting on each anniversary of the grant date.

Industry Context

StockSavvy.ai notes that the vesting of performance-based equity awards for a senior executive like a President & COO is a standard practice in the biotechnology and medical device industry, aligning executive incentives with long-term company performance and shareholder value creation. These types of disclosures are common for publicly traded companies as executives meet pre-defined operational or financial milestones.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards indicates that the company has met certain operational targets, which could be viewed positively. It also aligns executive incentives with shareholder interests.
• Employees: The achievement of operational targets may reflect overall company performance, potentially boosting morale.
• Management: Joseph E. Gilliam benefits directly from the vesting of his equity awards, increasing his ownership stake and compensation.

Next Steps

• 50% of a portion of a stock option award will vest and become exercisable in December 2026.
• Restricted stock units granted on March 25, 2026, will vest over a four-year period, with 25% vesting on each anniversary of the grant date.

Key Dates

Keywords

Glaukos Corp, GKOS, Joseph E Gilliam, Insider Trading, Form 4, Restricted Stock Units, Stock Options, Equity Awards, Executive Compensation, Performance-Based Vesting